1646-5830

S1646-58302022000400362

Portugal

30 12 2022

16 4 362 374

1896 6

133-7

2014

179515

2014 10

261-75

2004 18

177-200

2018 51

1-15

2002 94

1612-8

2005 14

2929-35

2006 21

1237-42

2008 19

843-6

2011 123

157-63

2015 15

751-9

2015 25

968-76

2016 143

87-92

2017 4

711-27

2017 28

437-45

2018 125

64-72

2019 299

35-46

2020 301

355-67

Task Force on carcinogenesis of endometrial cancer 2015 25

447-52

1925 10

1-72

1953 2

283-9

1979 53

318-23

1996 15

1-9

1996 11

641-6

1988 19

1080-4

2000 77

298-304

1997 30

249-55

Rora e Silva JC 2016 38

253-62

2014 93

20-31

2006 101

331-41

2003 13

466-71

2004 18

349-71

2012 13

385-94

2014 110

1878-90

2013 20

45-52

2013 14

18824-49

2017 35

110-6

1997 176

572-9

2015 94

2019 493

63-72

2020 8

1715

2015 4

2014 20

6163-74

2013 14

853-62

2008 14

32-40

2011 26

2262-7

2003 98

1658-63

2010 363

1532-43

2012 22

1310-5

2021 33

447-56

2015 8

1867-77

2015 6

6118

2016 84

1625-43

2012 43

1177-83

2015 144

452-63

1998 58

1707-12

Australian Ovarian Cancer StudyInternational Endogene Consortium 2015 24

5955-64

2018 50

190-204

2020 5

58-61

2017 6

152-6

2008 138

187-93

2015 185

23-7

2021 13

4026

2014 77

104-10

2017 376

1835-48

2019 7

D'Hooghe T.De Bie B.Heikinheimo O.Horne AW.Kiesel L.Nap A.Prentice A.Saridogan E.Soriano D.Nelen W.European Society of Human Reproduction and Embryology 2014 29

400-12

2013 208

413

2013 209

241

2013 58

469-76

2014 133

480-4

2019 3

100053

2016 34

148-54

2000 88

2584-9

2006 94

1369-74

2015 66

808-15

Vancouver Ovarian Clear Cell Symposium Speakers 2011 121

407-15

2012 126

481-90

2015 139

236-41

2018 11

2017 8

1093

2017 56

55-61

2016 26

52-5

2015 24

335-44

2019 45

766-86

2020 12

1676

2016 106

1432-7

2011 12

996

2018 17

210-6

2012 125

376-80

2020 83

227-32

2019 51

202-6

2007 105

801-12

2020 42

507-9

2013 28

1552-68